Jeffrey Low, MD is a life sciences and healthcare venture capital and growth equity investor based in the San Francisco Bay Area.

​

He is currently a Principal at Novo Growth where he leads investments in next generation life sciences, healthcare, and technology companies with a target initial investment size of $40M to $200M. He joined Novo Growth from Andreessen Horowitz (a16z) with previous investing experience at Novartis Venture Fund and Google Capital (now CapitalG). He is a frequent speaker, moderator, and expert on precision medicine, AI in drug discovery, and life sciences platforms.

​

Jeffrey received an MD from Yale School of Medicine, an MBA from Harvard Business School, and an AB in Molecular and Cellular Biology from Harvard. He has been named to Forbes 30 under 30 in Venture Capital.

He is a third generation San Franciscan and an avid squash player. 

​